DUOFAG is an investigational medication being tested for treating bacterial infections in patients with complicated wounds. It is designed to reduce or completely eliminate certain bacteria, specifically Staphylococcus aureus and Pseudomonas aeruginosa, which are common bacteria that can infect wounds and prevent them from healing properly. The medication is applied directly to the wound over a period of two weeks to help fight the infection and improve wound healing.

Staphylococcal Wound Infection – This is a bacterial infection of wounds caused by Staphylococcus aureus bacteria. The infection can occur in surgical wounds, traumatic wounds, or chronic wounds that are not healing properly. When present, the bacteria multiply in the wound tissue and prevent normal healing processes. The wound may show signs of infection such as redness, swelling, warmth, and discharge. Instead of healing directly, the wound must heal through a slower process involving the formation of granulation tissue. This type of infection complicates the wound healing process and requires the wound to close from the bottom up rather than the edges coming together.

Pseudomonas Wound Infection – This is a bacterial infection of wounds caused by Pseudomonas aeruginosa bacteria. This organism commonly infects wounds that are already damaged or not healing well. The bacteria can colonize both acute wounds such as those from surgery or injury, and chronic wounds that have been present for extended periods. Pseudomonas infection interferes with the normal wound healing process and causes the wound to heal through secondary intention with granulation tissue formation. The presence of this bacteria in wounds often leads to delayed healing and complications. Like other wound infections, it prevents the wound edges from closing directly and requires a longer healing time.